Analyst Price Targets — VERU
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 3, 2024 11:38 am | Yi Chen | H.C. Wainwright | $3.00 | $1.67 | TheFly | Veru price target raised to $3 from $2 at H.C. Wainwright |
| April 15, 2024 5:50 am | Leland Gershell | Oppenheimer | $5.00 | $1.52 | StreetInsider | Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer |
| December 7, 2022 6:28 am | — | H.C. Wainwright | $18.00 | $5.66 | Benzinga | HC Wainwright & Co. Maintains Buy on Veru, Lowers Price Target to $18 |
| April 15, 2022 11:26 am | Leland Gershell | Oppenheimer | $36.00 | $14.95 | Pulse 2.0 | Veru (VERU) Stock: $36 Price Target And Outperform Rating |
Latest News for VERU
MIAMI, FL, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that Mitchell Steiner, M.D.
Veru Inc. (VERU) Q3 2026 Earnings Call Transcript
-- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients –
-- When issued U.S. patent protection until at least October 2044 -- -- Allowed patent adds to already issued enobosarm specific molecule polymorph composition of matter patents, as well as number of other pending methods of use and formulation patent applications --
MIAMI, FL, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Monday, August 10, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 third quarter financial results and to provide a business…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VERU.
U.S. House Trading
No House trades found for VERU.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.